Literature DB >> 2475133

Semisynthesis of Arg15, Glu15, Met15, and Nle15-aprotinin involving enzymatic peptide bond resynthesis.

J Beckmann1, A Mehlich, W Schröder, H R Wenzel, H Tschesche.   

Abstract

The semisynthesis of homologues of aprotinin, the bovine pancreatic trypsin inhibitor, is described. The P1 lysine15 residue was replaced by two methods. The first procedure, which consisted of two enzymatic steps for the incorporation of other amino acids has previously been described. The second approach consisted of six steps of both enzymatic and chemical nature. The modified inhibitor, in which the lysine15-alanine16 peptide bond is hydrolyzed, was used as the starting material. All carboxyl groups of the modified inhibitor were esterified with methanol; the lysine15 methylester group was then selectively hydrolyzed. Afterward, lysine15 itself was split off. Arginine, glutamic acid, methionine, and L-2-aminohexanoic acid (norleucine, Nle) were incorporated using water-soluble carbodiimide combined with an acylation catalyst. The methylester group was used to prevent polymerization. The reactive-site peptide bonds were resynthesized using either chymotrypsin or trypsin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475133     DOI: 10.1007/bf01025082

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  35 in total

1.  Semisynthetic engineering of proteinase inhibitor homologues.

Authors:  H Tschesche; J Beckmann; A Mehlich; E Schnabel; E Truscheit; H R Wenzel
Journal:  Biochim Biophys Acta       Date:  1987-05-27

2.  Advantages of picrate fixation for staining polypeptides in polyacrylamide gels.

Authors:  J L Stephano; M Gould; L Rojas-Galicia
Journal:  Anal Biochem       Date:  1986-02-01       Impact factor: 3.365

3.  Expression, isolation and characterization of recombinant [Arg15,Glu52]aprotinin.

Authors:  E A Auerswald; D Hörlein; G Reinhardt; W Schröder; E Schnabel
Journal:  Biol Chem Hoppe Seyler       Date:  1988-05

4.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

5.  The basic trypsin inhibitor of bovine pancreas. I. Structure analysis and conformation of the polypeptide chain.

Authors:  R Huber; D Kukla; A Rühlmann; O Epp; H Formanek
Journal:  Naturwissenschaften       Date:  1970-08

Review 6.  Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs.

Authors:  H Fritz; G Wunderer
Journal:  Arzneimittelforschung       Date:  1983

7.  Staphylococcal protease: a proteolytic enzyme specific for glutamoyl bonds.

Authors:  J Houmard; G R Drapeau
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

8.  Removal of t-butyl and t-butoxycarbonyl protecting groups with trifluoroacetic acid. Mechanisms, biproduct formation and evaluation of scavengers.

Authors:  B F Lundt; N L Johansen; A Vølund; J Markussen
Journal:  Int J Pept Protein Res       Date:  1978-11

9.  Altered specificities of genetically engineered alpha 1 antitrypsin variants.

Authors:  S Jallat; D Carvallo; L H Tessier; D Roecklin; C Roitsch; F Ogushi; R G Crystal; M Courtney
Journal:  Protein Eng       Date:  1986 Oct-Nov

10.  The refined 2.2-A (0.22-nm) X-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the Arg15 analogue of bovine pancreatic trypsin inhibitor.

Authors:  W Bode; J Walter; R Huber; H R Wenzel; H Tschesche
Journal:  Eur J Biochem       Date:  1984-10-01
View more
  3 in total

1.  Chemical semisynthesis of aprotinin homologues and derivatives mutated in P' positions.

Authors:  C Groeger; H R Wenzel; H Tschesche
Journal:  J Protein Chem       Date:  1991-10

2.  Enzymatic semisynthesis of aprotinin homologues mutated in P' positions.

Authors:  C Groeger; H R Wenzel; H Tschesche
Journal:  J Protein Chem       Date:  1991-04

Review 3.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.